Now live on Kraken 📣$RSC by @researchhubStart trading today ⤵️https://t.co/PvG0GKZ4H0 https://t.co/H8Q4qadaGv ...

Core Insights - Silo Pharma has initiated its first Bitcoin purchase as part of a broader crypto reserve strategy aimed at multi-chain asset growth [1][2] - The CEO of Silo Pharma expressed confidence in Bitcoin as a store of value and a hedge against market volatility, highlighting the company's commitment to digital asset investments [2] - Silo Pharma's portfolio includes various therapeutic programs targeting conditions such as PTSD, fibromyalgia, and CNS diseases, developed in collaboration with leading universities [3] Company Overview - Silo Pharma operates as a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company [3] - The company focuses on addressing underserved medical conditions, including stress-induced psychiatric disorders and chronic pain [3] - Silo's innovative programs include SPC-15 for PTSD and SP-26 for fibromyalgia, along with preclinical assets for Alzheimer's disease and multiple sclerosis [3]

Core Insights - Silo Pharma has initiated its first Bitcoin purchase as part of a broader crypto reserve strategy aimed at multi-chain asset growth [1][2] - The CEO of Silo Pharma expressed confidence in Bitcoin as a store of value and a hedge against market volatility, highlighting the company's commitment to digital asset investments [2] - Silo Pharma's portfolio includes various therapeutic programs targeting conditions such as PTSD, fibromyalgia, and CNS diseases, indicating a diversified focus beyond cryptocurrency [3] Company Overview - Silo Pharma is a developmental-stage biopharmaceutical and cryptocurrency treasury company, focusing on underserved medical conditions [3] - The company collaborates with leading universities and laboratories for its research initiatives [3] Investment Strategy - The company has made multiple crypto investments, including Ethereum, RSC, and Solano tokens, and plans to continue expanding its digital asset portfolio [2] - The strategic approach reflects the company's belief in the growing adoption and value creation opportunities within the cryptocurrency market [2]

Source:Coinbase Assets 🛡️ (@CoinbaseAssets):Assets added to the roadmap today: ResearchCoin (RSC)https://t.co/rRB9d3hSr2 ...

$RSC pumped 32.1% in the last 4 hours after it was added to Base. https://t.co/R8NV6OI3Uz ...

Coinbase added $RSC today to its listings roadmap-Brian Armstrong is a ResearchHub co-founder-its a platform that uses blockchain and crypto incentives to accelerate and improve collaboration in scientific research-RSC token was created by the ResearchHub Foundation to reward community contributors-their mission is to use the RSC token to accelerate scientific research-Armstrong is not involved in Coinbase’s asset approval process-Armstrong and ResearchHub have never sold-Armstrong commits to not selling fo ...